You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
生物科技股表现抢眼 药明生物涨逾6% 大和呼吁抄底
格隆汇 03-11 10:18
格隆汇3月11日丨药明生物涨(2269.HK)逾6%,报93.45港元。大和昨日发表研究报告,指药明生物较历史高位累跌逾33%,其市值对积压订单比率由三周前的6.1倍降至4.1倍,过去三年均值则为5.5倍。该行称,未见公司基本面改变,近期大幅调整主要反映疫情后市场情绪偏好旧经济股;药明生物是其康健板块覆盖股份中最具防守性,近期股价过度调整带来“捞底”机会,重申买入,目标价135港元,并为行业首选。其它生物科技股亦表现抢眼,荣昌生物涨11.2%,药明巨诺涨近10%,永泰生物涨逾7%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account